Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy - PubMed (original) (raw)

Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy

T W Kim et al. Proc Natl Acad Sci U S A. 1992.

Abstract

Duchenne muscular dystrophy (DMD) is a common, lethal, chromosome X-linked inherited disease. Moderate cognitive impairment is a feature of DMD, but the underlying mechanisms are unknown. DMD is characterized by a defect in a protein, dystrophin, that is located predominantly in muscle but has been detected in brain. We sought to directly localize dystrophin within the complex synaptic structure of the cerebral cortex by focusing on the postsynaptic density (PSD), which appears to be central to synaptic function. We report that a specific anti-dystrophin antibody (anti 6-10) recognizes three distinct proteins in the purified PSD: the 400-kDa dystrophin and two previously unidentified dystrophin-related proteins of 120 and 110 kDa. These proteins exhibited differential regional expression in PSDs from cerebral cortex, cerebellum, and olfactory bulb. In the cortical PSD, the 400-kDa dystrophin was predominant, whereas the 120-kDa protein was the major species in cerebellum and olfactory bulb PSDs. The three proteins were differentially expressed in the PSD during cortical development: the 400-kDa protein exhibited a selective 9-fold increase during postnatal days 7 to 10, suggesting a normal physiological role in synaptic maturation. The PSD from the mdx mouse, a model of human DMD, contained no detectable 400-kDa dystrophin but expressed the two dystrophin-related proteins. Our results indicate that brain dystrophins are localized to the PSD, potentially as three isoforms, and raise the possibility that cognitive abnormalities in DMD are attributable to synaptic dysfunction associated with deficits in brain dystrophin molecules.

PubMed Disclaimer

Cited by

Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.
Rae MG, O'Malley D. Rae MG, et al. J Neurophysiol. 2016 Sep 1;116(3):1304-15. doi: 10.1152/jn.00248.2016. Epub 2016 Jul 6. J Neurophysiol. 2016. PMID: 27385793 Free PMC article. Review.
Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy.
Culligan K, Glover L, Dowling P, Ohlendieck K. Culligan K, et al. BMC Cell Biol. 2001;2:2. doi: 10.1186/1471-2121-2-2. Epub 2001 Feb 2. BMC Cell Biol. 2001. PMID: 11178104 Free PMC article.
Different dystrophin-like complexes are expressed in neurons and glia.
Blake DJ, Hawkes R, Benson MA, Beesley PW. Blake DJ, et al. J Cell Biol. 1999 Nov 1;147(3):645-58. doi: 10.1083/jcb.147.3.645. J Cell Biol. 1999. PMID: 10545507 Free PMC article.
Cerebellar-dependent associative learning is preserved in Duchenne muscular dystrophy: a study using delay eyeblink conditioning.
Schara U, Busse M, Timmann D, Gerwig M. Schara U, et al. PLoS One. 2015 May 14;10(5):e0126528. doi: 10.1371/journal.pone.0126528. eCollection 2015. PLoS One. 2015. PMID: 25973604 Free PMC article.
Partial Restoration of Brain Dystrophin and Behavioral Deficits by Exon Skipping in the Muscular Dystrophy X-Linked (mdx) Mouse.
Zarrouki F, Relizani K, Bizot F, Tensorer T, Garcia L, Vaillend C, Goyenvalle A. Zarrouki F, et al. Ann Neurol. 2022 Aug;92(2):213-229. doi: 10.1002/ana.26409. Epub 2022 Jun 13. Ann Neurol. 2022. PMID: 35587226 Free PMC article.

References

1. J Cell Biol. 1991 Oct;115(2):411-21 - PubMed
1. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
1. Nature. 1989 Apr 6;338(6215):509-11 - PubMed
1. Neuron. 1989 Jan;2(1):1019-29 - PubMed
1. Proc Natl Acad Sci U S A. 1985 May;82(10):3494-8 - PubMed

Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy - PubMed (original) (raw)